US Representative

Rudy Yakym Authored & Sponsored Legislation

Session

Cosponsor of Legislation

US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB141

Introduced
1/3/25  
Refer
1/3/25  
Trailer Safety Improvement ActThis bill requires that state highway safety programs address trailer safety equipment, preventive maintenance, and other aspects of the proper and safe usage of light- and medium-duty trailers.
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1468

Introduced
2/21/25  
Protect America’s Innovation and Economic Security from CCP Act of 2025

Original Cosponsor of Legislation

US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1672

Introduced
2/27/25  
Maintaining Investments in New Innovation Act This bill requires drug products with genetically targeted technology to have had market approval for at least 11 years in order to qualify for the Medicare Drug Price Negotiation Program. (The program requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain prescription drugs under Medicare beginning in 2026. Among other requirements, drugs must have had market approval for at least 7 years (for drug products) or 11 years (for biologics) to qualify for negotiation.)